Approval to combine the carbomedics prosthetic heart valve (cphv; approved on september 29, 1993 under p900060) with the sulzer vascutek gelweave valsalva vascular prosthesis (cleared on june 13, 2002 under k013022).  The device, as modified, will be marketed under the trade name carbomedics carbo-seal valsalva ascending aortic prosthesis, model cp-(size), will be available in sizes 21, 23, 25, 27, 29, 31, and 33 mm, and is indicated for use in open heart surgery for simultaneous replacement of the ascending aorta and the aortic valve in cases of aneurysm, dissection, or other disease conditions of the aorta combined with disease or degeneration of the aortic valve.